AARTIDRUGS

Aarti Drugs Share Price Aarti Drugs

₹499.9
-0.85 (-0.17%)
25 April, 2024 13:02 BSE: 524348 NSE: AARTIDRUGSISIN: INE767A01016

Start SIP in Aarti Drugs

Start SIP

Aarti Drugs Performance

Day Range

  • Low 499
  • High 504
₹ 499

52 Week Range

  • Low 409
  • High 646
₹ 499
  • Open Price499
  • Previous Close501
  • Volume37349

Aarti Drugs Share Price

  • Over 1 Month +9.72%
  • Over 3 Month -6.6%
  • Over 6 Month +3.23%
  • Over 1 Year +18.84%

Aarti Drugs Key Statistics

P/E Ratio 25.5
PEG Ratio 2.9
Market Cap Cr 4,596
Price to Book Ratio 3.9
EPS 16.6
Dividend 0.2
Relative Strength Index 57.67
Money Flow Index 82.96
MACD Signal 3.07
Average True Range 15.54
Aarti Drugs Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 538578592696
Operating Expenses Qtr Cr 478512520608
Operating Profit Qtr Cr 60657289
Depreciation Qtr Cr 12121212
Interest Qtr Cr 7888
Tax Qtr Cr 11121416
Net Profit Qtr Cr 32354053
IndicatorMar 2023
Total Revenue Annual Cr 2,500
Operating Expenses Annual Cr 2,216
Operating Profit Annual in Cr 282
Depreciation Cr 47
Interest Annual Cr 33
Tax Annual Cr 52
Net Profit Annual Cr 153
IndicatorMar 2023
Cash from Operating Activity Annual Cr 162
Cash from Investing Activity Annual Cr -131
Cash from Financing Annual Activity Cr -31
Net Cash Flow Annual Cr 1
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,114
Fixed Assets Annual Cr 795
Total Non Current Assets Annual Cr 846
Total Current Assets Annual Cr 1,350
Total Assets Annual Cr 2,195
IndicatorMar 2023
Book Value Per Share Annual Rs 120
ROE Annual % 14
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 606642661742
Operating Expenses Qtr Cr 536565577649
Operating Profit Qtr Cr 70768494
Depreciation Qtr Cr 13131313
Interest Qtr Cr 8899
Tax Qtr Cr 15171617
Net Profit Qtr Cr 37404856
IndicatorMar 2023
Total Revenue Annual Cr 2,718
Operating Expenses Annual Cr 2,410
Operating Profit Annual in Cr 306
Depreciation Cr 50
Interest Annual Cr 33
Tax Annual Cr 58
Net Profit Annual Cr 166
IndicatorMar 2023
Cash from Operating Activity Annual Cr 134
Cash from Investing Activity Annual Cr -164
Cash from Financing Annual Activity Cr 17
Net Cash Flow Annual Cr -13
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,192
Fixed Assets Annual Cr 887
Total Non Current Assets Annual Cr 929
Total Current Assets Annual Cr 1,492
Total Assets Annual Cr 2,421
IndicatorMar 2023
Book Value Per Share Annual Rs 129
ROE Annual % 14
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11

Aarti Drugs Technicals

EMA & SMA

Current Price
₹499.9
-0.85 (-0.17%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹488.28
  • 50 Day
  • ₹489.61
  • 100 Day
  • ₹495.70
  • 200 Day
  • ₹495.38
  • 20 Day
  • ₹481.69
  • 50 Day
  • ₹491.15
  • 100 Day
  • ₹499.09
  • 200 Day
  • ₹516.19

Aarti Drugs Resistance and Support

PIVOT
₹502.12
Resistance
First Resistance 505.23
Second Resistance 509.72
Third Resistance 512.83
RSI 57.67
MFI 82.96
MACD Single Line 3.07
MACD 5.64
Support
First Resistance 497.63
Second Resistance 494.52
Third Resistance 490.03

Aarti Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 87,963 4,733,289 53.81
Week 158,512 5,709,595 36.02
1 Month 277,081 11,424,069 41.23
6 Month 332,217 12,803,631 38.54

Aarti Drugs Result Highlights

Aarti Drugs Synopsis

NSE-Medical-Diversified

Aarti Drugs Ltd is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2497.97 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2023. Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433.
Market Cap 4,604
Sales 2,404
Shares in Float 3.95
No of funds 85
Yield 0.2
Book Value 4.16
U/D Vol ratio 1.1
LTDebt / Equity 15
Alpha -0.02
Beta 0.92

Aarti Drugs

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 57.13%57.47%58.56%58.7%
Mutual Funds 5.08%5.18%5.22%4.63%
Insurance Companies 0.08%0.08%0.1%0.08%
Foreign Portfolio Investors 2.56%2.1%2.33%1.97%
Financial Institutions/ Banks
Individual Investors 25.12%25.84%24.65%25.35%
Others 10.03%9.33%9.14%9.27%

Aarti Drugs Management

Name Designation
Mr. Chandrakant V Gogri Chairman Emeritus
Mr. Prakash M Patil Chairman & M.D & CEO
Mr. Rashesh C Gogri Managing Director
Mr. Harshit M Savla Joint Managing Director
Mr. Harit P Shah Executive Director
Mr. Uday M Patil Executive Director
Mrs. Neha R Gada Independent Director
CA. Navin C Shah Independent Director
Dr. Krishnacharya G Akamanchi Independent Director
Prof. Bhaskar N Thorat Independent Director
Mrs. Priti P Savla Independent Director
Mr. Ankit V Paleja Independent Director
Mr. Narendra J Salvi Non Executive Director

Aarti Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarti Drugs Corporate Action

Date Purpose Remarks
2024-01-24 Quarterly Results & Interim Dividend
2023-10-19 Quarterly Results
2023-07-21 Quarterly Results & Buy Back
2023-04-29 Audited Results
2023-01-27 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-06 INTERIM Rs.1.00 per share(10%)Interim Dividend
2023-02-08 INTERIM Rs.1.00 per share(10%)Interim Dividend
2022-02-10 INTERIM Rs.1.00 per share(10%)Interim Dividend

Aarti Drugs FAQs

What is Share Price of Aarti Drugs ?

Aarti Drugs share price is ₹499 As on 25 April, 2024 | 12:48

What is the Market Cap of Aarti Drugs ?

The Market Cap of Aarti Drugs is ₹4595.8 Cr As on 25 April, 2024 | 12:48

What is the P/E ratio of Aarti Drugs ?

The P/E ratio of Aarti Drugs is 25.5 As on 25 April, 2024 | 12:48

What is the PB ratio of Aarti Drugs ?

The PB ratio of Aarti Drugs is 3.9 As on 25 April, 2024 | 12:48

Q2FY23